ATOSSA THERAPEUTICS, INC. Loss Contingency Accrual, Period Increase (Decrease)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Loss Contingency Accrual, Period Increase (Decrease) of -$208.11 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease · last filed 2014-11-12
- ATOSSA THERAPEUTICS, INC. loss contingency accrual, period increase (decrease) for the quarter ending 2014-09-30 was -$8.64K, a 102.15% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. loss contingency accrual, period increase (decrease) for the quarter ending 2014-06-30 was -$84.17K.
- ATOSSA THERAPEUTICS, INC. loss contingency accrual, period increase (decrease) for the quarter ending 2014-03-31 was -$115.29K.
- ATOSSA THERAPEUTICS, INC. loss contingency accrual, period increase (decrease) for the quarter ending 2013-09-30 was $402.84K.
| Period end | Loss Contingency Accrual, Period Increase (Decrease) 3 month | Loss Contingency Accrual, Period Increase (Decrease) 6 month | Loss Contingency Accrual, Period Increase (Decrease) 9 month | Loss Contingency Accrual, Period Increase (Decrease) 59 month |
|---|---|---|---|---|
| 2014-09-30 | -$8.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$92.82K derived: sum of 2 quarters · filed 2014-11-12 | -$208.11K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$84.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$199.47K 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | -$115.29K 10-Q · filed 2014-05-14 | -$115.29K 10-Q · filed 2014-05-14 | ||
| 2013-09-30 | $402.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $402.84K derived: sum of 2 quarters · filed 2014-11-12 | $402.84K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |